Netherlands· NL-eb29922ff278
Nuovopan 20 mg/2 ml oplossing voor injectie/infusie
A nefopam product containing nefopamhydrochloride, registered in Netherlands by Prolepha Research B.V.. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Nefopam is registered in 7 of 19 countries.
Countries holding a registration under ATC N02BG06 (nefopam), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 4 of them publish a price we can compare per daily dose
Nefopam · ATC N02BG06
7 / 19 countries
- Belgiumprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Spainprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- NEFOPAMHYDROCHLORIDE
- Manufacturer
- Prolepha Research B.V.
- Country
- Netherlands (NL)
- ATC code
- N02BG06
- ATC class
- Nefopam
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129615
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nefopam in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceACUPAN 20 mg/2 mL, solution injectableBIOCODEX
- United KingdomAcupan 20mg/1ml solution for injection ampoules3M Health Care Ltd
- PolandNefopam HolstenHolsten Pharma GmbH
- BelgiumAcupan 30 mgViatris
- SpainNEPHODOL 20 MG/2 ML SOLUCIÓN INYECTABLE EFGAltan Pharmaceuticals S.A.
- IrelandAzuzote 30 mg film-coated tabletsAzure Pharmaceuticals Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Cyprus · Panagesic
- Estonia · Anefaltic, Nefomed
- Spain · Nephodol
- France · Acupan, Nefopam Arrow
- United Kingdom (Northern Ireland) · Nefopam Hydrochloride, Nefopam Hydrochloride 30 Mg
- Croatia · Nefalgic
- Ireland · Azuzote, Nefopam Hydrochloride Brown & Burk Ir
- Lithuania · Anefaltic
- Latvia · Anefaltic
- Malta · Nefopam Hydrochloride Ria Generics, Nuovopan
- Poland · Nefopam Holsten, Nefopam Jelfa
- Romania · Acupan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4761134b-8504-437f-8463-8cc494b8701b GET /v1/drugs/4761134b-8504-437f-8463-8cc494b8701b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie of infusie",
"route": "Intraveneus gebruik, Intramusculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129615_smpc.pdf",
"strength": null,
"atc_label": "Nefopam",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129615",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 12-WATER (E 339)",
"FOSFORZUUR (E 338)",
"NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
"NATRIUMHYDROXIDE (E 524)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"NEFOPAMHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129615.pdf",
"authorised_at": "2023/02/17",
"procedure_number": "EE/H/0363/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "129615",
"additional_monitoring": "N"
}See everything about nefopam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.